Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects

被引:93
作者
Parry, DE
Busse, WW
Sukow, KA
Dick, CR
Swenson, C
Gern, JE
机构
[1] Univ Wisconsin Hosp, Dept Pediat, Madison, WI 54792 USA
[2] Univ Wisconsin Hosp, Dept Med, Madison, WI 54792 USA
关键词
Rhinovirus; mononuclear cells; proliferation; common cold; blood; allergy; asthma;
D O I
10.1067/mai.2000.104785
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: The immune response to rhinovirus (RV) infections is considered to contribute to upper respiratory symptoms and may also be an important contributor to lower airway dysfunction in patients with asthma. Objective: This study was conducted to determine the relationship of RV-specific responses in PBMCs to the outcome of experimentally induced infection with RV16. Methods: Twenty-two subjects with either allergic rhinitis or asthma were inoculated with RV16: virus-induced proliferation and cytokine production were determined on PBMCs obtained before and then again 7 and 28 days after inoculation. Results: Several subjects had proliferative responses to RV16 before inoculation, and precold RV-specific proliferative responses were inversely correlated (r(s) = -0.62, P <.005) with RV shedding after inoculation. In addition, there was a negative correlation (r(s) = -0.58, P = 0.01) between precold RV-induced IFN-gamma secretion ex vivo and peak RV shedding during the cold. Conclusions: Certain RV-specific lymphocyte responses before the fold (vigorous proliferation or IFN-gamma secretion) were associated with reduced viral shedding after inoculation. These Endings suggest that variations in mononuclear cell responses to RV could contribute to the individual variability in viral shedding during experimentally induced, and perhaps naturally acquired, RV infections in subjects with respiratory allergy or asthma.
引用
收藏
页码:692 / 698
页数:7
相关论文
共 33 条
[1]   Prechallenge antibodies: Moderators of infection rate, signs, and symptoms in adults experimentally challenged with rhinovirus type 39 [J].
Alper, CM ;
Doyle, WJ ;
Skoner, DP ;
Buchman, CA ;
Seroky, JT ;
Gwaltney, JM ;
Cohen, SA .
LARYNGOSCOPE, 1996, 106 (10) :1298-1305
[2]   Prechallenge antibodies moderate disease expression in adults experimentally exposed to rhinovirus strain Hanks [J].
Alper, CM ;
Doyle, WJ ;
Skoner, DP ;
Buchman, CA ;
Cohen, S ;
Gwaltney, JM .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (01) :119-128
[3]   DISTINCT TYPES OF LUNG-DISEASE CAUSED BY FUNCTIONAL SUBSETS OF ANTIVIRAL T-CELLS [J].
ALWAN, WH ;
KOZLOWSKA, WJ ;
OPENSHAW, PJM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) :81-89
[4]   EXPERIMENTAL RHINOVIRUS-16 INFECTION POTENTIATES HISTAMINE-RELEASE AFTER ANTIGEN BRONCHOPROVOCATION IN ALLERGIC SUBJECTS [J].
CALHOUN, WJ ;
SWENSON, CA ;
DICK, EC ;
SCHWARTZ, LB ;
LEMANSKE, RF ;
BUSSE, WW .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (06) :1267-1273
[5]   RHINOVIRUS INHALATION CAUSES LONG-LASTING EXCESSIVE AIRWAY NARROWING IN RESPONSE TO METHACHOLINE IN ASTHMATIC SUBJECTS IN-VIVO [J].
CHEUNG, D ;
DICK, EC ;
TIMMERS, MC ;
DEKLERK, EPA ;
SPAAN, WJM ;
STERK, PJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (05) :1490-1496
[6]   Effector CD4(+) and CD8(+) T-cell mechanisms in the control of respiratory virus infections [J].
Doherty, PC ;
Topham, DJ ;
Tripp, RA ;
Cardin, RD ;
Brooks, JW ;
Stevenson, PG .
IMMUNOLOGICAL REVIEWS, 1997, 159 :105-117
[7]   RHINOVIRUS-39 INFECTION IN ALLERGIC AND NONALLERGIC SUBJECTS [J].
DOYLE, WJ ;
SKONER, DP ;
FIREMAN, P ;
SEROKY, JT ;
GREEN, I ;
RUBEN, F ;
KARDATZKE, DR ;
GWALTNEY, JM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (05) :968-978
[8]  
DUFF AL, 1993, PEDIATRICS, V92, P535
[9]  
EGGLESTON PA, 1984, ACTA OTO-LARYNGOL, P25
[10]   Virus-induced airway hyperresponsiveness and asthma [J].
Folkerts, G ;
Busse, WW ;
Nijkamp, FP ;
Sorkness, R ;
Gern, JE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (06) :1708-1720